Open Access. Powered by Scholars. Published by Universities.®

Pharmacoeconomics and Pharmaceutical Economics Commons™

Open Access. Powered by Scholars. Published by Universities.®

CentraCare Health

Articles 1 - 1 of 1

Full-Text Articles in Pharmacoeconomics and Pharmaceutical Economics

Decreasing Unnecessary Pharmacy Cost In The Cath Lab, Scott M. Scepaniak, Kristi Patterson Jan 2018

Decreasing Unnecessary Pharmacy Cost In The Cath Lab, Scott M. Scepaniak, Kristi Patterson

Nursing Posters

AngioMax is a single dose heparin alternative introduced in 2002 that is used in cardiac patients undergoing percutaneous intervention (PCI). Bivalirudin costs $377 per dose; heparin is less than $15 per dose. Noting practice variations, the Cath Lab set out to eliminate unnecessary pharmacy cost for PCI patients by:

  • Using current literature to inform clinical care
  • Standardizing practice
  • Using data to track and guide implementation

Go to article